NovelTargetsLab_Palencia_Inserm retweeted
Interested in doing a PhD in #NMR and #smFRET? We are looking for a PhD candidate to study intrinsically disordered proteins using integrated spectroscopic approaches @LeibnizFMP .
NovelTargetsLab_Palencia_Inserm retweeted
À l’occasion de la semaine mondiale pour un bon usage des antimicrobiens, l’#ANR, l’@Inserm
et l’ITMO I3M organisent le 22 novembre 2022 un colloque scientifique à Aubervilliers pour faire le point sur 10 ans de #recherche sur l’#antibiorésistance.
👉 https://teapawt.net/t.co/t0HnKFGUJh
NovelTargetsLab_Palencia_Inserm retweeted
Epic #keynote now from another #NMR #legend @Ad_Bax_4NMR showing some heroic #NMR on #SARSCoV2 #MPro perpetuating the dodgy #NMRacronyms by using #SILLY (Selective Inversion of Labile Ligand assemblY) w a little help from, you guessed it, #AlphaFold
NovelTargetsLab_Palencia_Inserm retweeted
I have an opening for a postdoc to study the role of disordered scaffold proteins in MAPK cell signaling by #NMR and other complementary techniques @IBS_Grenoble. If you are interested, send me an email, otherwise please RT.
NovelTargetsLab_Palencia_Inserm retweeted
New pub @ID30_MASSIF1 from @IBS_Grenoble and @IAB_Officiel in @Nature Visualizing protein breathing motions associated with aromatic ring flipping doi.org/10.1038/s41586-022-0…
NovelTargetsLab_Palencia_Inserm retweeted
It seems that infectious diseases and drug development are popular topics in 2020, but let's put viruses aside for a moment, there are other pathogens too! Check out our review on how aminoacyl-tRNA synthetases can be used as drug targets: sciencedirect.com/science/ar…
NovelTargetsLab_Palencia_Inserm retweeted
Endonuclease CPSF3 inhibition against Toxoplasma & related #malaria-causing parasites #OpenAccess #WorldMalariaDay
embomolmed.embopress.org/con…
NovelTargetsLab_Palencia_Inserm retweeted
Endonuclease CPSF3 inhibition against Toxoplasma & related #malaria-causing parasites @UGrenobleAlpes @UCSFMedicine embomolmed.embopress.org/con…
NovelTargetsLab_Palencia_Inserm retweeted
"It makes me so happy to see our structures guiding dev of new compounds" Andrés Palencia news.embl.de/lab-matters/160… teapawt.net/embl/status/7756950030…
Replying to @embl
After 10 years: a new, orally available, anti-TB drug candidate news.embl.de/science/new-dru… #antibioticresistance















